Intrinsic Value of S&P & Nasdaq Contact Us

Tvardi Therapeutics, Inc. TVRD

NASDAQ Global Market

SharesGrow Score
51/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.50
+42.4%

Tvardi Therapeutics, Inc. (TVRD) current share price is $3.16. The gold spot price is $4,825.20 per troy ounce. Using the formula: TVRD in gold = $3.16 × 31.1035 ÷ $4,825.20 = 0.0204 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of TVRD when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding TVRD shares over the measured period.

TVRD in US Dollars
Gold in US Dollars
TVRD in Gold (grams per share)

Real Wealth Growth Rate

TVRD
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{TVRD}_{\text{gold}}(t) = \frac{P_{\text{TVRD}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{TVRD}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{TVRD}_{\text{gold}}^{(T)}}{\text{TVRD}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{TVRD}_\text{gold}^{(0)}$ = initial gold-price, $\text{TVRD}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

PDSB
PDSB
PDS Biotechnology Corporation
$1.06
-2.75%
XLO
XLO
Xilio Therapeutics, Inc.
$8.59
+1.54%
ELUT
ELUT
Elutia Inc.
$1.11
+0.91%
LVTX
LVTX
LAVA Therapeutics N.V.
$1.74
-3.87%
FGEN
FGEN
FibroGen, Inc.
$9.07
-1.63%
ATNM
ATNM
Actinium Pharmaceuticals, Inc.
$1.10
-0.90%
LTRN
LTRN
Lantern Pharma Inc.
$2.33
+4.95%
TPST
TPST
Tempest Therapeutics, Inc.
$2.25
+5.14%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message